Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

2020 ASCO Virtual Scientific Program

GENITOURINARY CANCERS

Research news

24-06-2020 | ASCO 2020 | Conference coverage | News

Antiandrogen therapy boosts nonmetastatic CRPC survival

17-06-2020 | ASCO 2020 | Conference coverage | News

Immunotherapy de-escalation in advanced RCC not feasible yet

16-06-2020 | ASCO 2020 | Conference coverage | News

FRACTION-RCC suggests nivolumab–ipilimumab benefit for some ICI-treated RCC patients

12-06-2020 | ASCO 2020 | Conference coverage | News

RCC studies identify biomarkers of PD-1 inhibitor outcomes

12-06-2020 | ASCO 2020 | Conference coverage | News

Second-line lenvatinib–pembrolizumab shows promise for metastatic ccRCC

11-06-2020 | ASCO 2020 | Conference coverage | News

CONDOR: 18F-DCFPyL PET diagnoses biochemically recurrent prostate cancer

10-06-2020 | ASCO 2020 | News

Cabozantinib–atezolizumab duo shows urothelial cancer potential in COSMIC-021 study

09-06-2020 | ASCO 2020 | News

KEYNOTE-426 update ‘continues to support’ pembrolizumab plus axitinib

04-06-2020 | ASCO 2020 | News

HIF-2α inhibition ‘promising’ for von Hippel–Lindau disease-associated RCC

02-06-2020 | ASCO 2020 | News

Relugolix may offer better testosterone suppression than leuprolide

01-06-2020 | ASCO 2020 | News

IMvigor010: No atezolizumab benefit for muscle-invasive urothelial carcinoma

30-05-2020 | ASCO 2020 | News

Maintenance avelumab ‘new standard of care’ for advanced urothelial cancer

See the latest

Access all of our breaking news and expert commentary in the area of genitourinary cancers

Access content here

Expert video commentary

05-06-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: Updated KEYNOTE-426 data

Elizabeth Plimack presents the 2-year update of the KEYNOTE-426 study pitting the combination of pembrolizumab plus axitinib against sunitinib for treatment-naïve advanced renal cell carcinoma (1:45).

This independent video interview was supported by an educational grant from Pfizer and Merck KGaA

04-06-2020 | ASCO 2020 | Conference coverage | Video

Expert highlights: Genitourinary cancers at ASCO 2020

Axel Merseburger takes us through his picks of the genitourinary cancers track of the virtual 2020 ASCO Annual Meeting, including the JAVELIN Bladder 100 and KEYNOTE-426 trials (10:28).

04-06-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: The KEYNOTE-146/Study 111 trial

Chung-Han Lee reports the final analysis of KEYNOTE-146/Study 111 trial of lenvatinib plus pembrolizumab in metastatic clear-cell renal cell carcinoma after immune checkpoint inhibitor therapy (4:57).

This independent video interview was supported by an educational grant from Pfizer and Merck KGaA

03-06-2020 | ASCO 2020 | Conference coverage | Video

Expert comment: The JAVELIN Bladder 100 study

01-06-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: The JAVELIN Bladder 100 trial

01-06-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: Initial data from CCC19

01-06-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: The FRACTION-RCC study

31-05-2020 | ASCO 2020 | Conference coverage | Video

Expert comment: Antiandrogens in nonmetastatic CRPC

31-05-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: The TheraP trial

29-05-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: The SAVOIR trial

29-05-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: Perioperative durvalumab for locally advanced RCC

29-05-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: The SPARTAN OS data


Medicine Matters conference coverage is brought to you in partnership with medwireNews
  • » This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.
Image Credits